List of works - Tina S Skinner-Adams

A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery

scientific article published on 8 December 2022

A novel Plasmodium falciparum ring stage protein, REX, is located in Maurer's clefts

scientific article (publication date: August 2004)

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites

scientific article published on 26 March 2018

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

scientific article published on 25 April 2016

Aminopeptidases of malaria parasites: new targets for chemotherapy.

scientific article published on June 2010

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

scientific article published on 02 November 2020

An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery

scientific article published on 13 March 2020

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

scientific article published on 16 September 2020

Antimalarial Isocyano and Isothiocyanato Sesquiterpenes with Tri- and Bicyclic Skeletons from the Nudibranch Phyllidia ocellata

scientific article published on 09 June 2015

Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.

scientific article published on 14 September 2013

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

scientific article published on March 2007

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

scientific article

Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors

scientific article published on 22 December 2009

Antiplasmodial activity of the natural product compounds alstonine and himbeline

scientific article published in August 2021

Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.

scientific article

Antiretrovirals as antimalarial agents.

scientific article published on 3 November 2004

CLAG 9 is located in the rhoptries of Plasmodium falciparum.

scientific article published on 21 April 2004

Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

scientific article published on 10 November 2017

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

scientific article (publication date: 19 January 2007)

Characterization of the effect of retinol on Plasmodium falciparum in vitro.

scientific article published in July 2004

Comparison of Plasmodium falciparum transfection methods

scientific article

Correction to Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1

scientific article published on 31 July 2018

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone

scientific article published on 03 May 2019

Defining the targets of antiparasitic compounds.

scientific article

Drug repurposing and human parasitic protozoan diseases

scientific article

Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis

scientific article published on 17 January 2020

Effect of antimalarial drugs on Plasmodium falciparum gametocytes.

scientific article published in November 2009

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

scientific article published on 23 December 2016

Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126].

scientific article published on 30 May 2016

Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum

scientific article

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry

scientific article published on 13 February 2018

GATEWAY vectors for Plasmodium falciparum transfection

scientific article published on 01 January 2003

HIV and malaria co-infection: interactions and consequences of chemotherapy.

scientific article published on 02 May 2008

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study

scientific article published on 28 November 2011

HIV-malaria interactions: don't forget the drugs.

scientific article published in March 2007

Heterogeneous activity in vitro of vitamin A (retinol) in combination with novel and established antimalarial drugs.

scientific article published in September 1999

Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice

scientific article published in December 2021

Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.

scientific article

Identification of novel quinazoline derivatives as potent antiplasmodial agents

scientific article published on 17 October 2018

Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.

scientific article published on 26 October 2007

Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis

scientific article published on 19 January 2005

In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone

scientific article published on 01 January 2000

In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum.

scientific article published in May 1998

Inhibition of growth in vitro of Plasmodium falciparum by vitamin E (alpha-tocopherol).

scientific article

Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics

scientific article

Inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase

scientific article

Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase

scientific article published on 18 September 2014

Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases

scientific article published on 01 December 2006

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

scientific article

Malaria transfection and transfection vectors.

scientific article

Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244).

scientific article published on 11 March 2014

Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin

scientific article published on 14 November 2005

Plagiarism

scientific article published in August 2009

Plasmodium falciparum gametocytes: with a view to a kill.

scientific article published on 19 August 2013

Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials

scientific article published on 30 September 2009

Plasmodium falciparum: isolate-specific radiosensitivity.

scientific article published in October 2001

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

scientific article

Plasmodium gametocyte inhibition identified from a natural-product-based fragment library

scientific article

Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria

scientific article

Potent antimalarial activity of histone deacetylase inhibitor analogues.

scientific article published on 22 January 2008

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

scientific article published on 20 June 2015

Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins

Psammaplysin derivatives from the Balinese marine sponge Aplysinella strongylata

scientific article

Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.

scientific article

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

scientific article published on 28 April 2008

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase

scientific article

Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases

scientific article

Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity

scientific article published on 19 February 2019

Synergistic in vitro antimalarial activity of omeprazole and quinine.

scientific article

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

scientific article published on 6 November 2006

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.

scientific article

Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.

scientific article published on 4 February 2014

Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum

scientific article published on 23 December 2016

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria ⬇️

scientific article published on March 26, 2012

The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment ⬇️

scientific article published on April 3, 2012

The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.

scientific article published on 8 December 2020

The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.

scientific article published in June 2009

The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.

scientific article published on 20 August 2007

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.

scientific article

The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro ⬇️

scientific article published on September 1, 1997

Thieno[3,2-b]pyrrole 5-carboxamides as potent and selective inhibitors of Giardia duodenalis

scientific article published in December 2023

Total synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria

scientific article

List of works by Tina S Skinner-Adams

A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery

A novel Plasmodium falciparum ring stage protein, REX, is located in Maurer's clefts

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

Aminopeptidases of malaria parasites: new targets for chemotherapy.

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

Antimalarial Isocyano and Isothiocyanato Sesquiterpenes with Tri- and Bicyclic Skeletons from the Nudibranch Phyllidia ocellata

Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors

Antiplasmodial activity of the natural product compounds alstonine and himbeline

Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.

Antiretrovirals as antimalarial agents.

CLAG 9 is located in the rhoptries of Plasmodium falciparum.

Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1.

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

Characterization of the effect of retinol on Plasmodium falciparum in vitro.

Comparison of Plasmodium falciparum transfection methods

Correction to Catalyst-Controlled Stereoselective Synthesis Secures the Structure of the Antimalarial Isocyanoterpene Pustulosaisonitrile-1

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone

Defining the targets of antiparasitic compounds.

Drug repurposing and human parasitic protozoan diseases

Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis

Effect of antimalarial drugs on Plasmodium falciparum gametocytes.

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

Erratum to "Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites" [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117-126].

Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum

Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry

GATEWAY vectors for Plasmodium falciparum transfection

HIV and malaria co-infection: interactions and consequences of chemotherapy.

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study

HIV-malaria interactions: don't forget the drugs.

Heterogeneous activity in vitro of vitamin A (retinol) in combination with novel and established antimalarial drugs.

Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice

Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.

Identification of novel quinazoline derivatives as potent antiplasmodial agents

Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.

Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis

In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone

In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum.

Inhibition of growth in vitro of Plasmodium falciparum by vitamin E (alpha-tocopherol).

Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics

Inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase

Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase

Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases

Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.

Malaria transfection and transfection vectors.

Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244).

Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin

Plagiarism

Plasmodium falciparum gametocytes: with a view to a kill.

Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials

Plasmodium falciparum: isolate-specific radiosensitivity.

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

Plasmodium gametocyte inhibition identified from a natural-product-based fragment library

Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria

Potent antimalarial activity of histone deacetylase inhibitor analogues.

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins

Psammaplysin derivatives from the Balinese marine sponge Aplysinella strongylata

Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase

Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases

Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity

Synergistic in vitro antimalarial activity of omeprazole and quinine.

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.

Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.

Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria ⬇️

The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment ⬇️

The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.

The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.

The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.